Global Sunitinib Malate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Sunitinib Malate market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.
This report is a detailed and comprehensive analysis for global Sunitinib Malate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sunitinib Malate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sunitinib Malate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sunitinib Malate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical, Hansoh Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sunitinib Malate market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sunitinib Malate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sunitinib Malate, with price, sales quantity, revenue, and global market share of Sunitinib Malate from 2020 to 2025.
Chapter 3, the Sunitinib Malate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sunitinib Malate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sunitinib Malate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sunitinib Malate.
Chapter 14 and 15, to describe Sunitinib Malate sales channel, distributors, customers, research findings and conclusion.
Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and c-kit, thereby inhibiting angiogenesis and cell proliferation. This agent also inhibits the phosphorylation of Fms-related tyrosine kinase 3 (FLT3), another receptor tyrosine kinase expressed by some leukemic cells.
This report is a detailed and comprehensive analysis for global Sunitinib Malate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sunitinib Malate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Sunitinib Malate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sunitinib Malate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sunitinib Malate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Nanjing First Pharmaceutical Co., Ltd., J&K Scientific, Target Molecule Corp., CSPC, Qilu Pharmaceutical, Hansoh Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sunitinib Malate market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 12.5mg
- 37.5mg
- 50mg
- Advanced Kidney Cancer
- GIST (Gastrointestinal Stromal Tumor)
- Pancreatic Neuroendocrine Tumors
- Pfizer Sutent
- Topcare pharmaceutical Co., Ltd
- Nanjing First Pharmaceutical Co., Ltd.
- J&K Scientific
- Target Molecule Corp.
- CSPC
- Qilu Pharmaceutical
- Hansoh Pharma
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sunitinib Malate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sunitinib Malate, with price, sales quantity, revenue, and global market share of Sunitinib Malate from 2020 to 2025.
Chapter 3, the Sunitinib Malate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sunitinib Malate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sunitinib Malate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sunitinib Malate.
Chapter 14 and 15, to describe Sunitinib Malate sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sunitinib Malate Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 12.5mg
1.3.3 37.5mg
1.3.4 50mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Sunitinib Malate Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Advanced Kidney Cancer
1.4.3 GIST (Gastrointestinal Stromal Tumor)
1.4.4 Pancreatic Neuroendocrine Tumors
1.5 Global Sunitinib Malate Market Size & Forecast
1.5.1 Global Sunitinib Malate Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Sunitinib Malate Sales Quantity (2020-2031)
1.5.3 Global Sunitinib Malate Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Pfizer Sutent
2.1.1 Pfizer Sutent Details
2.1.2 Pfizer Sutent Major Business
2.1.3 Pfizer Sutent Sunitinib Malate Product and Services
2.1.4 Pfizer Sutent Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pfizer Sutent Recent Developments/Updates
2.2 Topcare pharmaceutical Co., Ltd
2.2.1 Topcare pharmaceutical Co., Ltd Details
2.2.2 Topcare pharmaceutical Co., Ltd Major Business
2.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product and Services
2.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Topcare pharmaceutical Co., Ltd Recent Developments/Updates
2.3 Nanjing First Pharmaceutical Co., Ltd.
2.3.1 Nanjing First Pharmaceutical Co., Ltd. Details
2.3.2 Nanjing First Pharmaceutical Co., Ltd. Major Business
2.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product and Services
2.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 J&K Scientific
2.4.1 J&K Scientific Details
2.4.2 J&K Scientific Major Business
2.4.3 J&K Scientific Sunitinib Malate Product and Services
2.4.4 J&K Scientific Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 J&K Scientific Recent Developments/Updates
2.5 Target Molecule Corp.
2.5.1 Target Molecule Corp. Details
2.5.2 Target Molecule Corp. Major Business
2.5.3 Target Molecule Corp. Sunitinib Malate Product and Services
2.5.4 Target Molecule Corp. Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Target Molecule Corp. Recent Developments/Updates
2.6 CSPC
2.6.1 CSPC Details
2.6.2 CSPC Major Business
2.6.3 CSPC Sunitinib Malate Product and Services
2.6.4 CSPC Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSPC Recent Developments/Updates
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Sunitinib Malate Product and Services
2.7.4 Qilu Pharmaceutical Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Qilu Pharmaceutical Recent Developments/Updates
2.8 Hansoh Pharma
2.8.1 Hansoh Pharma Details
2.8.2 Hansoh Pharma Major Business
2.8.3 Hansoh Pharma Sunitinib Malate Product and Services
2.8.4 Hansoh Pharma Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Hansoh Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SUNITINIB MALATE BY MANUFACTURER
3.1 Global Sunitinib Malate Sales Quantity by Manufacturer (2020-2025)
3.2 Global Sunitinib Malate Revenue by Manufacturer (2020-2025)
3.3 Global Sunitinib Malate Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Sunitinib Malate by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Sunitinib Malate Manufacturer Market Share in 2024
3.4.3 Top 6 Sunitinib Malate Manufacturer Market Share in 2024
3.5 Sunitinib Malate Market: Overall Company Footprint Analysis
3.5.1 Sunitinib Malate Market: Region Footprint
3.5.2 Sunitinib Malate Market: Company Product Type Footprint
3.5.3 Sunitinib Malate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Sunitinib Malate Market Size by Region
4.1.1 Global Sunitinib Malate Sales Quantity by Region (2020-2031)
4.1.2 Global Sunitinib Malate Consumption Value by Region (2020-2031)
4.1.3 Global Sunitinib Malate Average Price by Region (2020-2031)
4.2 North America Sunitinib Malate Consumption Value (2020-2031)
4.3 Europe Sunitinib Malate Consumption Value (2020-2031)
4.4 Asia-Pacific Sunitinib Malate Consumption Value (2020-2031)
4.5 South America Sunitinib Malate Consumption Value (2020-2031)
4.6 Middle East & Africa Sunitinib Malate Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Sunitinib Malate Sales Quantity by Type (2020-2031)
5.2 Global Sunitinib Malate Consumption Value by Type (2020-2031)
5.3 Global Sunitinib Malate Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Sunitinib Malate Sales Quantity by Application (2020-2031)
6.2 Global Sunitinib Malate Consumption Value by Application (2020-2031)
6.3 Global Sunitinib Malate Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Sunitinib Malate Sales Quantity by Type (2020-2031)
7.2 North America Sunitinib Malate Sales Quantity by Application (2020-2031)
7.3 North America Sunitinib Malate Market Size by Country
7.3.1 North America Sunitinib Malate Sales Quantity by Country (2020-2031)
7.3.2 North America Sunitinib Malate Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Sunitinib Malate Sales Quantity by Type (2020-2031)
8.2 Europe Sunitinib Malate Sales Quantity by Application (2020-2031)
8.3 Europe Sunitinib Malate Market Size by Country
8.3.1 Europe Sunitinib Malate Sales Quantity by Country (2020-2031)
8.3.2 Europe Sunitinib Malate Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Sunitinib Malate Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Sunitinib Malate Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Sunitinib Malate Market Size by Region
9.3.1 Asia-Pacific Sunitinib Malate Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Sunitinib Malate Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Sunitinib Malate Sales Quantity by Type (2020-2031)
10.2 South America Sunitinib Malate Sales Quantity by Application (2020-2031)
10.3 South America Sunitinib Malate Market Size by Country
10.3.1 South America Sunitinib Malate Sales Quantity by Country (2020-2031)
10.3.2 South America Sunitinib Malate Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Sunitinib Malate Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Sunitinib Malate Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Sunitinib Malate Market Size by Country
11.3.1 Middle East & Africa Sunitinib Malate Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Sunitinib Malate Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Sunitinib Malate Market Drivers
12.2 Sunitinib Malate Market Restraints
12.3 Sunitinib Malate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Sunitinib Malate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sunitinib Malate
13.3 Sunitinib Malate Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sunitinib Malate Typical Distributors
14.3 Sunitinib Malate Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Sunitinib Malate Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Sunitinib Malate Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Pfizer Sutent Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Sutent Major Business
Table 5. Pfizer Sutent Sunitinib Malate Product and Services
Table 6. Pfizer Sutent Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Pfizer Sutent Recent Developments/Updates
Table 8.Topcare pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 9.Topcare pharmaceutical Co., Ltd Major Business
Table 10.Topcare pharmaceutical Co., Ltd Sunitinib Malate Product and Services
Table 11.Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12.Topcare pharmaceutical Co., Ltd Recent Developments/Updates
Table 13. NanjingFirst Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. NanjingFirst Pharmaceutical Co., Ltd. Major Business
Table 15. NanjingFirst Pharmaceutical Co., Ltd. Sunitinib Malate Product and Services
Table 16. NanjingFirst Pharmaceutical Co., Ltd. Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. NanjingFirst Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. J&K Scientific Basic Information, Manufacturing Base and Competitors
Table 19. J&K Scientific Major Business
Table 20. J&K Scientific Sunitinib Malate Product and Services
Table 21. J&K Scientific Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. J&K Scientific Recent Developments/Updates
Table 23.Target Molecule Corp. Basic Information, Manufacturing Base and Competitors
Table 24.Target Molecule Corp. Major Business
Table 25.Target Molecule Corp. Sunitinib Malate Product and Services
Table 26.Target Molecule Corp. Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Target Molecule Corp. Recent Developments/Updates
Table 28. CSPC Basic Information, Manufacturing Base and Competitors
Table 29. CSPC Major Business
Table 30. CSPC Sunitinib Malate Product and Services
Table 31. CSPC Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSPC Recent Developments/Updates
Table 33. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Pharmaceutical Major Business
Table 35. Qilu Pharmaceutical Sunitinib Malate Product and Services
Table 36. Qilu Pharmaceutical Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Qilu Pharmaceutical Recent Developments/Updates
Table 38. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Hansoh Pharma Major Business
Table 40. Hansoh Pharma Sunitinib Malate Product and Services
Table 41. Hansoh Pharma Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Hansoh Pharma Recent Developments/Updates
Table 43. Global Sunitinib Malate Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 44. Global Sunitinib Malate Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. Global Sunitinib Malate Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 46. Market Position of Manufacturers in Sunitinib Malate, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 47. Head Office and Sunitinib Malate Production Site of Key Manufacturer
Table 48. Sunitinib Malate Market: Company ProductTypeFootprint
Table 49. Sunitinib Malate Market: Company Product ApplicationFootprint
Table 50. Sunitinib Malate New Market Entrants and Barriers to Market Entry
Table 51. Sunitinib Malate Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Sunitinib Malate Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. Global Sunitinib Malate Sales Quantity by Region (2020-2025) & (K Units)
Table 54. Global Sunitinib Malate Sales Quantity by Region (2026-2031) & (K Units)
Table 55. Global Sunitinib Malate Consumption Value by Region (2020-2025) & (USD Million)
Table 56. Global Sunitinib Malate Consumption Value by Region (2026-2031) & (USD Million)
Table 57. Global Sunitinib Malate Average Price by Region (2020-2025) & (US$/Unit)
Table 58. Global Sunitinib Malate Average Price by Region (2026-2031) & (US$/Unit)
Table 59. Global Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 60. Global Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 61. Global Sunitinib Malate Consumption Value byType (2020-2025) & (USD Million)
Table 62. Global Sunitinib Malate Consumption Value byType (2026-2031) & (USD Million)
Table 63. Global Sunitinib Malate Average Price byType (2020-2025) & (US$/Unit)
Table 64. Global Sunitinib Malate Average Price byType (2026-2031) & (US$/Unit)
Table 65. Global Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 66. Global Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 67. Global Sunitinib Malate Consumption Value by Application (2020-2025) & (USD Million)
Table 68. Global Sunitinib Malate Consumption Value by Application (2026-2031) & (USD Million)
Table 69. Global Sunitinib Malate Average Price by Application (2020-2025) & (US$/Unit)
Table 70. Global Sunitinib Malate Average Price by Application (2026-2031) & (US$/Unit)
Table 71. North America Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 72. North America Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 73. North America Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 74. North America Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 75. North America Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 76. North America Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 77. North America Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 80. Europe Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 81. Europe Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 82. Europe Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 83. Europe Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 84. Europe Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 85. Europe Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 86. Europe Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-Pacific Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 88. Asia-Pacific Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 89. Asia-Pacific Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 90. Asia-Pacific Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 91. Asia-Pacific Sunitinib Malate Sales Quantity by Region (2020-2025) & (K Units)
Table 92. Asia-Pacific Sunitinib Malate Sales Quantity by Region (2026-2031) & (K Units)
Table 93. Asia-Pacific Sunitinib Malate Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-Pacific Sunitinib Malate Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South America Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 96. South America Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 97. South America Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 98. South America Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 99. South America Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 100. South America Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 101. South America Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South America Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & Africa Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 104. Middle East & Africa Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 105. Middle East & Africa Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 106. Middle East & Africa Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 107. Middle East & Africa Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 108. Middle East & Africa Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 109. Middle East & Africa Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & Africa Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 111. Sunitinib Malate Raw Material
Table 112. Key Manufacturers of Sunitinib Malate Raw Materials
Table 113. Sunitinib MalateTypical Distributors
Table 114. Sunitinib MalateTypical Customers
LIST OFFIGURES
Figure 1. Sunitinib Malate Picture
Figure 2. Global Sunitinib Malate Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Sunitinib Malate Revenue Market Share byType in 2024
Figure 4. 12.5mg Examples
Figure 5. 37.5mg Examples
Figure 6. 50mg Examples
Figure 7. Global Sunitinib Malate Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Sunitinib Malate Revenue Market Share by Application in 2024
Figure 9. Advanced Kidney Cancer Examples
Figure 10. GIST (Gastrointestinal StromalTumor) Examples
Figure 11. Pancreatic NeuroendocrineTumors Examples
Figure 12. Global Sunitinib Malate Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Sunitinib Malate Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Sunitinib Malate Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Sunitinib Malate Price (2020-2031) & (US$/Unit)
Figure 16. Global Sunitinib Malate Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Sunitinib Malate Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Sunitinib Malate by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19.Top 3 Sunitinib Malate Manufacturer (Revenue) Market Share in 2024
Figure 20.Top 6 Sunitinib Malate Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Sunitinib Malate Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Sunitinib Malate Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 29. Global Sunitinib Malate Consumption Value Market Share byType (2020-2031)
Figure 30. Global Sunitinib Malate Average Price byType (2020-2031) & (US$/Unit)
Figure 31. Global Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Sunitinib Malate Revenue Market Share by Application (2020-2031)
Figure 33. Global Sunitinib Malate Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 35. North America Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 42. Europe Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 46.France Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 51. Asia-Pacific Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Sunitinib Malate Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Sunitinib Malate Consumption Value Market Share by Region (2020-2031)
Figure 54. China Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 57. India Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 61. South America Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 67. Middle East & Africa Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 70.Turkey Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 74. Sunitinib Malate Market Drivers
Figure 75. Sunitinib Malate Market Restraints
Figure 76. Sunitinib Malate MarketTrends
Figure 77. PortersFiveForces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Sunitinib Malate in 2024
Figure 79. Manufacturing Process Analysis of Sunitinib Malate
Figure 80. Sunitinib Malate Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Sunitinib Malate Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 12.5mg
1.3.3 37.5mg
1.3.4 50mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Sunitinib Malate Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Advanced Kidney Cancer
1.4.3 GIST (Gastrointestinal Stromal Tumor)
1.4.4 Pancreatic Neuroendocrine Tumors
1.5 Global Sunitinib Malate Market Size & Forecast
1.5.1 Global Sunitinib Malate Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Sunitinib Malate Sales Quantity (2020-2031)
1.5.3 Global Sunitinib Malate Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Pfizer Sutent
2.1.1 Pfizer Sutent Details
2.1.2 Pfizer Sutent Major Business
2.1.3 Pfizer Sutent Sunitinib Malate Product and Services
2.1.4 Pfizer Sutent Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Pfizer Sutent Recent Developments/Updates
2.2 Topcare pharmaceutical Co., Ltd
2.2.1 Topcare pharmaceutical Co., Ltd Details
2.2.2 Topcare pharmaceutical Co., Ltd Major Business
2.2.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product and Services
2.2.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Topcare pharmaceutical Co., Ltd Recent Developments/Updates
2.3 Nanjing First Pharmaceutical Co., Ltd.
2.3.1 Nanjing First Pharmaceutical Co., Ltd. Details
2.3.2 Nanjing First Pharmaceutical Co., Ltd. Major Business
2.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product and Services
2.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments/Updates
2.4 J&K Scientific
2.4.1 J&K Scientific Details
2.4.2 J&K Scientific Major Business
2.4.3 J&K Scientific Sunitinib Malate Product and Services
2.4.4 J&K Scientific Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 J&K Scientific Recent Developments/Updates
2.5 Target Molecule Corp.
2.5.1 Target Molecule Corp. Details
2.5.2 Target Molecule Corp. Major Business
2.5.3 Target Molecule Corp. Sunitinib Malate Product and Services
2.5.4 Target Molecule Corp. Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Target Molecule Corp. Recent Developments/Updates
2.6 CSPC
2.6.1 CSPC Details
2.6.2 CSPC Major Business
2.6.3 CSPC Sunitinib Malate Product and Services
2.6.4 CSPC Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 CSPC Recent Developments/Updates
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Sunitinib Malate Product and Services
2.7.4 Qilu Pharmaceutical Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Qilu Pharmaceutical Recent Developments/Updates
2.8 Hansoh Pharma
2.8.1 Hansoh Pharma Details
2.8.2 Hansoh Pharma Major Business
2.8.3 Hansoh Pharma Sunitinib Malate Product and Services
2.8.4 Hansoh Pharma Sunitinib Malate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Hansoh Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SUNITINIB MALATE BY MANUFACTURER
3.1 Global Sunitinib Malate Sales Quantity by Manufacturer (2020-2025)
3.2 Global Sunitinib Malate Revenue by Manufacturer (2020-2025)
3.3 Global Sunitinib Malate Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Sunitinib Malate by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Sunitinib Malate Manufacturer Market Share in 2024
3.4.3 Top 6 Sunitinib Malate Manufacturer Market Share in 2024
3.5 Sunitinib Malate Market: Overall Company Footprint Analysis
3.5.1 Sunitinib Malate Market: Region Footprint
3.5.2 Sunitinib Malate Market: Company Product Type Footprint
3.5.3 Sunitinib Malate Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Sunitinib Malate Market Size by Region
4.1.1 Global Sunitinib Malate Sales Quantity by Region (2020-2031)
4.1.2 Global Sunitinib Malate Consumption Value by Region (2020-2031)
4.1.3 Global Sunitinib Malate Average Price by Region (2020-2031)
4.2 North America Sunitinib Malate Consumption Value (2020-2031)
4.3 Europe Sunitinib Malate Consumption Value (2020-2031)
4.4 Asia-Pacific Sunitinib Malate Consumption Value (2020-2031)
4.5 South America Sunitinib Malate Consumption Value (2020-2031)
4.6 Middle East & Africa Sunitinib Malate Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Sunitinib Malate Sales Quantity by Type (2020-2031)
5.2 Global Sunitinib Malate Consumption Value by Type (2020-2031)
5.3 Global Sunitinib Malate Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Sunitinib Malate Sales Quantity by Application (2020-2031)
6.2 Global Sunitinib Malate Consumption Value by Application (2020-2031)
6.3 Global Sunitinib Malate Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Sunitinib Malate Sales Quantity by Type (2020-2031)
7.2 North America Sunitinib Malate Sales Quantity by Application (2020-2031)
7.3 North America Sunitinib Malate Market Size by Country
7.3.1 North America Sunitinib Malate Sales Quantity by Country (2020-2031)
7.3.2 North America Sunitinib Malate Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Sunitinib Malate Sales Quantity by Type (2020-2031)
8.2 Europe Sunitinib Malate Sales Quantity by Application (2020-2031)
8.3 Europe Sunitinib Malate Market Size by Country
8.3.1 Europe Sunitinib Malate Sales Quantity by Country (2020-2031)
8.3.2 Europe Sunitinib Malate Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Sunitinib Malate Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Sunitinib Malate Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Sunitinib Malate Market Size by Region
9.3.1 Asia-Pacific Sunitinib Malate Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Sunitinib Malate Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Sunitinib Malate Sales Quantity by Type (2020-2031)
10.2 South America Sunitinib Malate Sales Quantity by Application (2020-2031)
10.3 South America Sunitinib Malate Market Size by Country
10.3.1 South America Sunitinib Malate Sales Quantity by Country (2020-2031)
10.3.2 South America Sunitinib Malate Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Sunitinib Malate Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Sunitinib Malate Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Sunitinib Malate Market Size by Country
11.3.1 Middle East & Africa Sunitinib Malate Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Sunitinib Malate Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Sunitinib Malate Market Drivers
12.2 Sunitinib Malate Market Restraints
12.3 Sunitinib Malate Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Sunitinib Malate and Key Manufacturers
13.2 Manufacturing Costs Percentage of Sunitinib Malate
13.3 Sunitinib Malate Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Sunitinib Malate Typical Distributors
14.3 Sunitinib Malate Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OFTABLES
Table 1. Global Sunitinib Malate Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Sunitinib Malate Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Pfizer Sutent Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Sutent Major Business
Table 5. Pfizer Sutent Sunitinib Malate Product and Services
Table 6. Pfizer Sutent Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Pfizer Sutent Recent Developments/Updates
Table 8.Topcare pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 9.Topcare pharmaceutical Co., Ltd Major Business
Table 10.Topcare pharmaceutical Co., Ltd Sunitinib Malate Product and Services
Table 11.Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12.Topcare pharmaceutical Co., Ltd Recent Developments/Updates
Table 13. NanjingFirst Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 14. NanjingFirst Pharmaceutical Co., Ltd. Major Business
Table 15. NanjingFirst Pharmaceutical Co., Ltd. Sunitinib Malate Product and Services
Table 16. NanjingFirst Pharmaceutical Co., Ltd. Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. NanjingFirst Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 18. J&K Scientific Basic Information, Manufacturing Base and Competitors
Table 19. J&K Scientific Major Business
Table 20. J&K Scientific Sunitinib Malate Product and Services
Table 21. J&K Scientific Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. J&K Scientific Recent Developments/Updates
Table 23.Target Molecule Corp. Basic Information, Manufacturing Base and Competitors
Table 24.Target Molecule Corp. Major Business
Table 25.Target Molecule Corp. Sunitinib Malate Product and Services
Table 26.Target Molecule Corp. Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27.Target Molecule Corp. Recent Developments/Updates
Table 28. CSPC Basic Information, Manufacturing Base and Competitors
Table 29. CSPC Major Business
Table 30. CSPC Sunitinib Malate Product and Services
Table 31. CSPC Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. CSPC Recent Developments/Updates
Table 33. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Qilu Pharmaceutical Major Business
Table 35. Qilu Pharmaceutical Sunitinib Malate Product and Services
Table 36. Qilu Pharmaceutical Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Qilu Pharmaceutical Recent Developments/Updates
Table 38. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Hansoh Pharma Major Business
Table 40. Hansoh Pharma Sunitinib Malate Product and Services
Table 41. Hansoh Pharma Sunitinib Malate Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Hansoh Pharma Recent Developments/Updates
Table 43. Global Sunitinib Malate Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 44. Global Sunitinib Malate Revenue by Manufacturer (2020-2025) & (USD Million)
Table 45. Global Sunitinib Malate Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 46. Market Position of Manufacturers in Sunitinib Malate, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 47. Head Office and Sunitinib Malate Production Site of Key Manufacturer
Table 48. Sunitinib Malate Market: Company ProductTypeFootprint
Table 49. Sunitinib Malate Market: Company Product ApplicationFootprint
Table 50. Sunitinib Malate New Market Entrants and Barriers to Market Entry
Table 51. Sunitinib Malate Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Sunitinib Malate Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 53. Global Sunitinib Malate Sales Quantity by Region (2020-2025) & (K Units)
Table 54. Global Sunitinib Malate Sales Quantity by Region (2026-2031) & (K Units)
Table 55. Global Sunitinib Malate Consumption Value by Region (2020-2025) & (USD Million)
Table 56. Global Sunitinib Malate Consumption Value by Region (2026-2031) & (USD Million)
Table 57. Global Sunitinib Malate Average Price by Region (2020-2025) & (US$/Unit)
Table 58. Global Sunitinib Malate Average Price by Region (2026-2031) & (US$/Unit)
Table 59. Global Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 60. Global Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 61. Global Sunitinib Malate Consumption Value byType (2020-2025) & (USD Million)
Table 62. Global Sunitinib Malate Consumption Value byType (2026-2031) & (USD Million)
Table 63. Global Sunitinib Malate Average Price byType (2020-2025) & (US$/Unit)
Table 64. Global Sunitinib Malate Average Price byType (2026-2031) & (US$/Unit)
Table 65. Global Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 66. Global Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 67. Global Sunitinib Malate Consumption Value by Application (2020-2025) & (USD Million)
Table 68. Global Sunitinib Malate Consumption Value by Application (2026-2031) & (USD Million)
Table 69. Global Sunitinib Malate Average Price by Application (2020-2025) & (US$/Unit)
Table 70. Global Sunitinib Malate Average Price by Application (2026-2031) & (US$/Unit)
Table 71. North America Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 72. North America Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 73. North America Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 74. North America Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 75. North America Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 76. North America Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 77. North America Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 80. Europe Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 81. Europe Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 82. Europe Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 83. Europe Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 84. Europe Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 85. Europe Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 86. Europe Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 87. Asia-Pacific Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 88. Asia-Pacific Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 89. Asia-Pacific Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 90. Asia-Pacific Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 91. Asia-Pacific Sunitinib Malate Sales Quantity by Region (2020-2025) & (K Units)
Table 92. Asia-Pacific Sunitinib Malate Sales Quantity by Region (2026-2031) & (K Units)
Table 93. Asia-Pacific Sunitinib Malate Consumption Value by Region (2020-2025) & (USD Million)
Table 94. Asia-Pacific Sunitinib Malate Consumption Value by Region (2026-2031) & (USD Million)
Table 95. South America Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 96. South America Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 97. South America Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 98. South America Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 99. South America Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 100. South America Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 101. South America Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 102. South America Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Middle East & Africa Sunitinib Malate Sales Quantity byType (2020-2025) & (K Units)
Table 104. Middle East & Africa Sunitinib Malate Sales Quantity byType (2026-2031) & (K Units)
Table 105. Middle East & Africa Sunitinib Malate Sales Quantity by Application (2020-2025) & (K Units)
Table 106. Middle East & Africa Sunitinib Malate Sales Quantity by Application (2026-2031) & (K Units)
Table 107. Middle East & Africa Sunitinib Malate Sales Quantity by Country (2020-2025) & (K Units)
Table 108. Middle East & Africa Sunitinib Malate Sales Quantity by Country (2026-2031) & (K Units)
Table 109. Middle East & Africa Sunitinib Malate Consumption Value by Country (2020-2025) & (USD Million)
Table 110. Middle East & Africa Sunitinib Malate Consumption Value by Country (2026-2031) & (USD Million)
Table 111. Sunitinib Malate Raw Material
Table 112. Key Manufacturers of Sunitinib Malate Raw Materials
Table 113. Sunitinib MalateTypical Distributors
Table 114. Sunitinib MalateTypical Customers
LIST OFFIGURES
Figure 1. Sunitinib Malate Picture
Figure 2. Global Sunitinib Malate Revenue byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Sunitinib Malate Revenue Market Share byType in 2024
Figure 4. 12.5mg Examples
Figure 5. 37.5mg Examples
Figure 6. 50mg Examples
Figure 7. Global Sunitinib Malate Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Sunitinib Malate Revenue Market Share by Application in 2024
Figure 9. Advanced Kidney Cancer Examples
Figure 10. GIST (Gastrointestinal StromalTumor) Examples
Figure 11. Pancreatic NeuroendocrineTumors Examples
Figure 12. Global Sunitinib Malate Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Sunitinib Malate Consumption Value andForecast (2020-2031) & (USD Million)
Figure 14. Global Sunitinib Malate Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Sunitinib Malate Price (2020-2031) & (US$/Unit)
Figure 16. Global Sunitinib Malate Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Sunitinib Malate Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Sunitinib Malate by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19.Top 3 Sunitinib Malate Manufacturer (Revenue) Market Share in 2024
Figure 20.Top 6 Sunitinib Malate Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Sunitinib Malate Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Sunitinib Malate Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 29. Global Sunitinib Malate Consumption Value Market Share byType (2020-2031)
Figure 30. Global Sunitinib Malate Average Price byType (2020-2031) & (US$/Unit)
Figure 31. Global Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Sunitinib Malate Revenue Market Share by Application (2020-2031)
Figure 33. Global Sunitinib Malate Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 35. North America Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 42. Europe Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 46.France Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 51. Asia-Pacific Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Sunitinib Malate Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Sunitinib Malate Consumption Value Market Share by Region (2020-2031)
Figure 54. China Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 57. India Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 61. South America Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Sunitinib Malate Sales Quantity Market Share byType (2020-2031)
Figure 67. Middle East & Africa Sunitinib Malate Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Sunitinib Malate Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Sunitinib Malate Consumption Value Market Share by Country (2020-2031)
Figure 70.Turkey Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Sunitinib Malate Consumption Value (2020-2031) & (USD Million)
Figure 74. Sunitinib Malate Market Drivers
Figure 75. Sunitinib Malate Market Restraints
Figure 76. Sunitinib Malate MarketTrends
Figure 77. PortersFiveForces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Sunitinib Malate in 2024
Figure 79. Manufacturing Process Analysis of Sunitinib Malate
Figure 80. Sunitinib Malate Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
More Publications
Global Antirheumatics Pharmaceutical Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
US$ 3,480.00
November 2019
105 pages
Global Balloon Dilatation Catheter Market 2019 by Company, Regions, Type and Application, Forecast to 2024
US$ 3,480.00
April 2019
116 pages
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Pulmonary Drugs Market 2018, Forecast to 2023
US$ 4,880.00
January 2019
137 pages
North America and Europe Vaccine Refrigerators Market by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 4,480.00
June 2018
107 pages
